Male carriers are advised to undergo clinical breast exams starting at age 35 and prostate cancer screening with a digital rectal exam and prostate-specific antigen (PSA) testing starting at age 40, especially for BRCA2 carriers. This evidence concerns the gene BRCA2 and prostate cancer.